At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 27 enrolled
Drug / intervention
Tradipitant +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VP-VLY-686-1301: A Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy Volunteers
In Brief
A Phase 2 clinical trial evaluating Tradipitant and Placebo for Healthy Volunteer. Completed, enrolled 27 participants across 1 site.
Detailed Summary
To evaluate the effects of tradipitant relative to placebo on satiation, gastric volume, gastric accommodation, and gastric emptying in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteer
CountriesUnited States
CollaboratorsMayo Clinic
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartFeb 2021
First PostedApr 2021
Primary CompletionSep 2021
TodayJul 2026
First PostedApr 19, 2021
Enrollment StartFeb 1, 2021
Primary CompletionSep 24, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.2 years ago
Interventions
Tradipitantdrug
Tradipitant Capsule
Placebodrug
Placebo Capsule